phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

ASCO 2025 STUDY: New Standard of Care Emerges for Multiple Myeloma

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma. The randomized, multi-center ADVANCE clinical trial tests the effects of adding the targeted drug daratumumab to the standard three-part therapy regimen, called KRd (carfilzomib, lenalidomide and dexamethasone).

May 29, 2025


June 2 2025

June 1 2025

May 31 2025

May 30 2025

May 29 2025

May 28 2025

May 27 2025

May 26 2025

May 25 2025

May 24 2025

May 23 2025

May 22 2025

May 21 2025

May 20 2025

May 19 2025

Angell Street Psychiatry
Copyright 2025 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy